New anxiety drug shows promise in clinical trial
NCT ID NCT05749055
Summary
This study tested whether a new medication called ENX-102 helps reduce anxiety symptoms in adults with generalized anxiety disorder. Researchers compared ENX-102 against a placebo in 252 participants over several weeks. The main goal was to see if people taking ENX-102 experienced greater reductions in their anxiety levels than those taking the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Accel Research Sites Network - Lakeland CRU
Lakeland, Florida, 33803, United States
-
Accel Research Sites Network - Maitland CRU
Maitland, Florida, 32751, United States
-
Aim Trials
Plano, Texas, 75093, United States
-
Alliance Research
Long Beach, California, 90712, United States
-
Alpine Research Organization
Clinton, Utah, 84015, United States
-
Anderson Clinical Research
Redlands, California, 92374, United States
-
Austin Clinical Trials Partners
Austin, Texas, 78737, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Boston Clinical Trials
Boston, Massachusetts, 02131, United States
-
California Neuroscience Research, LLC
Sherman Oaks, California, 91403, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, 32256, United States
-
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, 32801, United States
-
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, 38119, United States
-
Collaborative Neuroscience Research, LLC (CNS)
Garden Grove, California, 92845, United States
-
Collective Medical Research
Overland Park, Kansas, 66210, United States
-
Core Clinical Research
Everett, Washington, 98201, United States
-
Excell Research, Inc.
Oceanside, California, 92056, United States
-
FutureSearch Trials of Dallas
Dallas, Texas, 75231, United States
-
Grayline Research Center
Wichita Falls, Texas, 76309, United States
-
IMA Clinical Research
Las Vegas, Nevada, 89102, United States
-
IMA Clinical Research Phoenix
Phoenix, Arizona, 85012, United States
-
Mountain View Clinical Research
Denver, Colorado, 80209, United States
-
NRC Research Institute
Los Angeles, California, 90015, United States
-
Neurobehavioral Research
Cedarhurst, New York, 11516, United States
-
Pacific Clinical Research Management Group
Upland, California, 91786, United States
-
Precise Research Centres
Flowood, Mississippi, 39232, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10314, United States
-
SPRI Clinical Trials, LLC
Brooklyn, New York, 11235, United States
-
Sun Valley Research Center
Imperial, California, 92251, United States
-
Sunwise Clinical Research
Walnut Creek, California, 94596, United States
-
Vertex Clinical Research
Clermont, Florida, 34711, United States
Conditions
Explore the condition pages connected to this study.